Patents Assigned to Avalon GloboCare Corp.
  • Patent number: 11939368
    Abstract: The present invention is directed to QTY CCR9 and CXCR2 variant Fc receptor fusion proteins, methods for the preparation thereof and methods of use thereof.
    Type: Grant
    Filed: July 29, 2022
    Date of Patent: March 26, 2024
    Assignees: Massachusetts Institute of Technology, Avalon GloboCare Corp.
    Inventors: Shuguang Zhang, David Jin, Rui Qing, Uwe Sleytr
  • Patent number: 11555060
    Abstract: The present invention is directed to QTY Fc receptor fusion proteins, methods for the preparation thereof and methods of use thereof.
    Type: Grant
    Filed: March 24, 2021
    Date of Patent: January 17, 2023
    Assignees: Avalon GloboCare Corp., Massachusetts Institute of Technology
    Inventors: David Jin, Rui Qing, Shuguang Zhang